This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Byong-Gon Park: Innovator in Calcium Channel Research
Introduction
Byong-Gon Park is a notable inventor based in Gangwon, South Korea. He has made significant contributions to the field of cellular biology, particularly in the development of innovative methods for high throughput screening of calcium channel inhibitors. His work is essential for advancing therapeutic agents for diseases associated with T-type calcium channels.
Latest Patents
Byong-Gon Park holds 1 patent related to a transfected cell line and a method for high throughput screening for inhibitors of the T-type calcium channel alpha-1H. This invention involves a cell line capable of activating the T-type α1H calcium channel by depolarization, achieved through the introduction of a vector encoding a potassium channel. The cell line is designed to facilitate the screening of candidate inhibitors, thereby accelerating the development of therapeutic agents for conditions linked to T-type α1H calcium channels.
Career Highlights
Park is affiliated with the Korea Institute of Science and Technology, where he continues to engage in groundbreaking research. His work has positioned him as a key figure in the study of calcium channels and their implications in various diseases.
Collaborations
Throughout his career, Byong-Gon Park has collaborated with esteemed colleagues, including Edward Perez-Reyes and Hee Sup Shin. These partnerships have further enriched his research and contributed to advancements in the field.
Conclusion
Byong-Gon Park's innovative work in the realm of calcium channel research exemplifies the impact of dedicated inventors in the scientific community. His contributions are paving the way for new therapeutic solutions in medicine.